breast cancer - HR positive | ||
la/mBC - HR positive - (neo)adjuvant (NA) | la/mBC - HR-positive - 2nd line (L2) | |
alpelisib based treatment | ||
alpelisib plus fulvestrant | SOLAR-1 ... SOLAR-1 ... | |
alpelisib plus letrozole | NEO-ORB ... NEO-ORB ... |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -